Stanford tests new pill to fight scarring in fatty liver disease
NCT ID NCT04669158
Summary
This study tested whether a pill called idebenone is safe and might help people with a serious fatty liver disease called NASH. It involved 53 adults with early to moderate liver scarring. Participants took either the study drug or a placebo for up to a year to see if the drug could reduce liver damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Digestive Health Center, Stanford University
Redwood City, California, 94063, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.